SAN DIEGO--(BUSINESS WIRE)--Feb. 23, 2006--Cytori Therapeutics, Inc. (NASDAQ: CYTX) (Frankfurt: XMPA) announced today it has granted Olympus Corporation an exclusive right to negotiate a commercialization collaboration for the use of adipose stem and regenerative cells for a specific therapeutic area outside of cardiovascular disease. In exchange for this right, Cytori will receive a $1.5 million payment from Olympus.
